Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Polypill for liver-related events in adults over 50 in the Golestan Cohort
IRCT201111204092N3Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Sep 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of aspirin + atorvastatin + hydrochlorothiazide + enalapril in metabolic dysfunction-associated steatohepatitis (MASH), sponsored by Tehran University of Medical Sciences. Started Sep 2011; status: completed.
02
Drugs
aspirin + atorvastatin + hydrochlorothiazide + enalapril
03
Conditions
metabolic dysfunction-associated steatohepatitis (MASH)
Beyond the preview
Go deeper on IRCT201111204092N3.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT201111204092N3.